title: Allopregnanolone association with psychophysiological and cognitive functions during acute smoking abstinence in premenopausal women.
abstract: Nicotine response may predict susceptibility to smoking relapse. Allopregnanolone, a neuroactive steroid metabolized from progesterone, has been shown to be associated with several symptoms of nicotine response. We sought to explore the association between allopregnanolone and response to nicotine during acute smoking abstinence in premenopausal women. Participants completed 2 nicotine-response laboratory sessions, 1 in their follicular (low allopregnanolone) and 1 in their luteal (high allopregnanolone) menstrual phase, on the fourth day of biochemically confirmed smoking abstinence. During the laboratory sessions, participants self-administered a nicotine nasal spray and completed a timed series of cardiovascular, cognitive, and subjective assessments of response to nicotine. The relationships of allopregnanolone with baseline values and change scores of outcome measures were assessed using covariance pattern modeling. Study participants (N = 77) had a mean age of 29.9 (SD = 6.8) years and smoked an average of 12.2 (SD = 4.9) cigarettes per day. Allopregnanolone concentration measured before nicotine administration was positively associated with systolic (β = 0.85, p = .04) and diastolic blood pressure (β = 1.19, p < .001) and self-report of physical symptoms (β = 0.58, p < .001), dizziness (β = 0.88, p < .01), jitteriness (β = 0.90, p = .04), and pleasantness (β = 2.05, p = .04). Allopregnanolone also had significant positive associations with change in cognition following nicotine nasal spray administration, specifically discriminability as a measure of attention (β = 1.15, p = .05) and response bias as a measure of impulsivity (β = 0.13, p = .02). These data suggest that allopregnanolone may be related to cardiovascular and subjective physical state during acute smoking abstinence, as well as cognitive response to nicotine.
authors: Department of Family Medicine & Community Health.
authors: Alicia M
authors: AM
authors: Allen
authors: Department of Behavioral Sciences, Medical School, University of Minnesota.
authors: Mustafa
authors: M
authors: al'Absi
authors: Department of Family Medicine & Community Health.
authors: Harry
authors: H
authors: Lando
authors: Department of Family Medicine & Community Health.
authors: Sharon S
authors: SS
authors: Allen
mesh_terms: D000293:Adolescent; D000328:Adult; D003071:Cognition; D005260:Female; D006801:Humans; D011280:Pregnanolone / Q000502:physiology*; D017697:Premenopause; D016540:Smoking Cessation / Q000523:psychology; D055815:Young Adult
chemical_list: D011280:Pregnanolone
references: Am J Public Health. 1987 Nov;77(11):1435-8
references: 3661797
references: Neurobehav Toxicol Teratol. 1985 Jul-Aug;7(4):415-8
references: 3840579
references: Behav Genet. 1995 Mar;25(2):161-77
references: 7733857
references: Exp Clin Psychopharmacol. 1997 Feb;5(1):83-90
references: 9234043
references: J Pharmacol Exp Ther. 1999 Jan;288(1):188-97
references: 9862770
references: Addict Behav. 1999 Jan-Feb;24(1):127-34
references: 10189980
references: Br J Clin Pharmacol. 2004 Dec;58(7):S720-40; discussion S741-3
references: 15595961
references: Biol Psychol. 2006 Jan;71(1):2-11
references: 15951099
references: Psychopharmacology (Berl). 2006 Jun;186(3):462-72
references: 16402195
references: Brain Res Rev. 2006 Aug;51(2):212-39
references: 16368148
references: J Womens Health (Larchmt). 2008 Mar;17(2):287-92
references: 18321180
references: J Womens Health (Larchmt). 2008 Mar;17(2):293-301
references: 18321181
references: Addiction. 2008 May;103(5):809-21
references: 18412759
references: Am J Epidemiol. 2009 Jan 15;169(2):236-48
references: 19019851
references: Prog Neurobiol. 2009 Oct;89(2):134-52
references: 19595736
references: Psychophysiology. 2010 May 1;47(3):550-9
references: 20070572
references: Neurosci Biobehav Rev. 2010 Nov;35(2):315-33
references: 20398693
references: Drug Alcohol Depend. 2011 Mar 1;114(1):68-72
references: 20832955
references: Neurosci Lett. 2013 Apr 29;541:144-9
references: 23485740
references: Nicotine Tob Res. 2013 Jun;15(6):1091-8
references: 23155122
references: Addict Behav. 2014 May;39(5):901-6
references: 24594903
references: Psychoneuroendocrinology. 2001 Oct;26(7):697-710
references: 11500251
references: Obstet Gynecol. 2001 Jan;97(1):77-80
references: 11152912
references: Behav Res Methods Instrum Comput. 2002 Aug;34(3):391-8
references: 12395555
references: Pharmacol Biochem Behav. 2003 Jan;74(2):401-10
references: 12479961
references: Drug Alcohol Depend. 2004 Mar 8;73(3):267-78
references: 15036549
references: Psychopharmacology (Berl). 1995 Jan;117(1):2-10; discussion 14-20
references: 7724697